ABCB5 is a multidrug resistance transporter recently shown to be preferentially expressed by cells of melanocytic lineage and to be responsible for conferring resistance to chemotherapy in vitro. For example, inhibition of ABCB5 renders normally resistant melanoma cells susceptible to doxorubicin. Subsequent work has shown that ABCB5 expression 1) marks melanoma cells of stem cell phenotype and function;2) correlates with tumorigenic growth of melanoma cells in vivo;and 3) is more abundant in human malignant melanoma than in benign melanocytic nevi. In tandem with fundamental approaches to further establishing ABCB5 as an identifier of melanoma stem cells (MF, separately funded), we here propose to explore the clinical relevance of ABCB5 as a biomarker of melanoma progression, prognosis, and outcome, as well as to demonstrate the therapeutic efficacy of ABCB5 targeting in a relevant animal model of human malignant melanoma. The technologies that will be employed to accomplish these goals range from tissue microarrays to detailed analysis of primary human melanomas supported by prognostic and outcome data to a SCID mouse bioassay in which melanomas develop in xenografted human skin in a manner that recapitulates naturally-occurring disease and in which ABCB5+ tumor cells may be therapeutically targeted. In sum, these approaches will determine the clinical relevance and therapeutic importance of this novel biomarker, and should pave the way to eventual clinical therapeutic trials focused on targeting of ABCB5* melanoma stem cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA093683-10
Application #
8380217
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
2014-01-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2012
Total Cost
$232,504
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Sung, Hyeran; Kanchi, Krishna L; Wang, Xue et al. (2016) Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation. Oncotarget 7:23885-96
Jain, Salvia; Stroopinsky, Dina; Yin, Li et al. (2015) Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 126:354-62
Lee, Jonathan J; Granter, Scott R; Laga, Alvaro C et al. (2015) 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol 28:218-29
Bhela, Siddheshvar; Kempsell, Christine; Manohar, Monali et al. (2015) Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol 194:2180-9
Lee, Jonathan J; Cook, Martin; Mihm, Martin C et al. (2015) Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget 6:37995-8004
Watanabe, Rei; Gehad, Ahmed; Yang, Chao et al. (2015) Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7:279ra39
Kirsch, Ilan R; Watanabe, Rei; O'Malley, John T et al. (2015) TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med 7:308ra158
Litvinov, Ivan V; Netchiporouk, Elena; Cordeiro, Brendan et al. (2015) The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL). Clin Cancer Res 21:2820-9
Yazawa, Erika M; Geddes-Sweeney, Jenna E; Cedeno-Laurent, Filiberto et al. (2015) Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential. J Invest Dermatol 135:1849-62
Lezcano, Cecilia; Lee, Chung-Wei; Larson, Allison R et al. (2014) Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors. Mod Pathol 27:1193-202

Showing the most recent 10 out of 129 publications